Journal Article10.1055/S-2002-23206
Extrahepatic portal vein obstruction.
218
TL;DR: Variceal bleeding in EHPVO can be successfully managed by endoscopic obliteration of varices, which has low morbidity but requires repeated visits, or by portosystemic shunt surgery, which provides good control of bleeding, possibly helps growth retardation, hypersplenism, and protects against future development of portal biliopathy.
read more
Abstract: Extrahepatic portal vein obstruction (EHPVO) is an important cause of noncirrhotic portal hypertension, especially in Third World countries. The etiology and clinical presentation are different in children and adults. The portal vein is transformed into a cavernoma, resulting in portal hypertension and oesophagogastic varices. In addition, extensive collateral circulation develops, involving paracholecystic, paracholedochal and pancreaticoduodenal veins resulting in formation of ectopic varices, and portal biliopathy. Besides variceal bleeding, which is the commonest presentation, patients may have symptomatic portal biliopathy, hypersplenism, and growth retardation. Although the liver may appear normal, functional compromise develops in the long term. Variceal bleeding in EHPVO can be successfully managed by endoscopic obliteration of varices, which has low morbidity but requires repeated visits, or by portosystemic shunt surgery, which provides good control of bleeding, possibly helps growth retardation, hypersplenism, and protects against future development of portal biliopathy but is associated with surgical mortality and is sometimes not feasible due to nonavailability of a satisfactory vessel.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
Lun-Xiu Qin,Zhao-You Tang +1 more
TL;DR: Molecular markers (biomarkers) for hepatocellular carcinoma (HCC) metastasis and recurrence could provide additional information to that gained from traditional histopathological features, as understanding of tumor biology deepens.
•Journal Article
Portal biliopathy treated with living-donor liver transplant: index case.
TL;DR: An index case treated successfully with living-donor liver transplant for portal biliopathy is reported, and the proposed therapies include endoscopic dilatation and stenting of the common bile duct, portosystemic shunt with splenectomy, meso Rex bypass, and occasionally, bilioenteric bypass.
Splenomegaly in Children and Adolescents.
TL;DR: In this article, a comprehensive list of differential diagnoses to be considered clinically in children and young adolescents is discussed, including infectious agents, hematologic disorders, infiltrative diseases, hyperplasia of the white pulp, congestion, and changes in the composition and structure of white pulp by immunologically mediated diseases.
Collateral Pathways in Portal Hypertension
TL;DR: The objective of this review is to illustrate the various PSCV and portoportal collateral vein pathways pertinent to portal hypertension in liver cirrhosis and EHPVO.
Therapeutic Challenges for Symptomatic Portal Cavernoma Cholangiopathy.
TL;DR: In selected cases, the mesocaval shunting plays an essential role in the treatment of portal cavernoma cholangiopathy even in the era of interventional radiology.
References
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
Marie-Hélène Denninger,Yasmine Chait,Nicole Casadevall,Sophie Hillaire,Marie-Claude Guillin,Annie Bezeaud,Serge Erlinger,Jean Briere,Dominique Valla +8 more
TL;DR: It is concluded that portal or hepatic venous thrombosis should be regarded as an index for 1 or several prothrombotic disorders, whether or not local precipitating factors or oral contraceptive use are found.
747
Incidence of portal vein thrombosis in liver cirrhosis: An angiographic study in 708 patients
Kunio Okuda,Kunihiko Ohnishi,Kunio Kimura,Shoichi Matsutani,Masatoshi Sumida,Nobuaki Goto,Hirotaka Musha,Motohide Takashi,Noriaki Suzuki,Takashi Shinagawa,Naondo Suzuki,Toshio Ohtsuki,Masahiro Arakawa,Toshiro Nakashima +13 more
TL;DR: In this article, the incidence of portal vein thrombosis was studied in 708 consecutive patients with unequivocal cirrhosis seen in the past 10 years in which either transhepatic portography or superior mesenteric arterial portography clearly delineated the major portal vein system.
391
Portal vein thrombosis: a review.
TL;DR: A comprehensive description of etiologic factors and clinical aspects of portal vein thrombosis is presented and a framework for the diagnostic work-up and management of patients with PVT is provided.
302
Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography.
TL;DR: After thrombosis of the portal vein, portoportal venous channels may form not only at the porta hepatis but also within the liver, suggesting that, despite extensive hemodynamic adaptations, portal hypertension ensues.
Portal obstruction in children. I. Clinical investigation and hemorrhage risk
Fernando Alvarez,Olivier Bernard,Francis Brunelle,P. Hadchouel,Michel Odièvre,Daniel Alagille +5 more
TL;DR: Angiography should be limited to children with a history of gastrointestinal tract bleeding for whom a surgical portosystemic shunt is being considered, and the presence of tense varices and congestion of esophageal mucosa clearly augmented the risk of bleeding.
198